92 related articles for article (PubMed ID: 19120937)
1. The Clip score: is it time to be clipped away?
Ray Kim W
Liver Int; 2009 Jan; 29(1):2-3. PubMed ID: 19120937
[No Abstract] [Full Text] [Related]
2. Is the Cancer of the Liver Italian Program system an adequate weighting for survival of hepatocellular carcinoma? Evaluation of intrascore prognostic value among 36 subgroups.
Lin CY; Kee KM; Wang JH; Lee CM; Chen CL; Changchien CS; Hu TH; Cheng YF; Hsu HC; Wang CC; Chen TY; Lu SN
Liver Int; 2009 Jan; 29(1):74-81. PubMed ID: 18331238
[TBL] [Abstract][Full Text] [Related]
3. Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems.
Huo TI; Hsia CY; Huang YH; Lin HC; Lee PC; Lui WY; Chiang JH; Chiou YY; Loong CC; Lee SD
J Clin Gastroenterol; 2009 Sep; 43(8):773-81. PubMed ID: 19262404
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma.
Ahn J; Flamm SL
Dis Mon; 2004 Oct; 50(10):556-73. PubMed ID: 15616490
[No Abstract] [Full Text] [Related]
5. Staging systems for hepatocellular carcinoma: should we all use the BCLC system?
Marrero JA
J Hepatol; 2006 Apr; 44(4):630-2. PubMed ID: 16503077
[No Abstract] [Full Text] [Related]
6. A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients.
Yen YH; Changchien CS; Wang JH; Kee KM; Hung CH; Hu TH; Lee CM; Lin CY; Wang CC; Chen TY; Huang YJ; Lu SN
Dig Liver Dis; 2009 Jun; 41(6):431-41. PubMed ID: 19185555
[TBL] [Abstract][Full Text] [Related]
7. Prognostication of the outcome of hepatocellular carcinoma: how to rely on science instead of on the art of Nostradamus.
Trevisani F; Santi V
Dig Liver Dis; 2009 Jun; 41(6):382-4. PubMed ID: 19328052
[No Abstract] [Full Text] [Related]
8. Usefulness of the CLIP scoring system for prediction of postoperative prognosis of patients with large hepatocellular carcinoma.
Noda T; Sasaki Y; Yamada T; Eguchi H; Yano M; Ohigashi H; Ishikawa O; Imaoka S
J Hepatobiliary Pancreat Surg; 2009; 16(4):538-45. PubMed ID: 19367360
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of new prognostic staging systems (SLiDe score) for hepatocellular carcinoma patients who underwent hepatectomy.
Nanashima A; Omagari K; Sumida Y; Abo T; Fukuoha H; Takeshita H; Hidaka S; Tanaka K; Sawai T; Yasutake T; Nagayasu T; Mizuta Y; Ohba K; Ohnita K; Kadokawa Y
Hepatogastroenterology; 2009; 56(93):1137-40. PubMed ID: 19760957
[TBL] [Abstract][Full Text] [Related]
10. [New surgical approaches in the treatment of hepatocellular carcinoma].
Hoffmann K; Schmidt J
Z Gastroenterol; 2009 Jan; 47(1):61-7. PubMed ID: 19156593
[TBL] [Abstract][Full Text] [Related]
11. Selection criteria for patients with hepatocellular carcinoma in liver transplantation.
Kaido T; Takada Y; Uemoto S
Transplantation; 2009 Aug; 88(3):442-3; author reply 443. PubMed ID: 19667951
[No Abstract] [Full Text] [Related]
12. Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method--analysis of 2010 Taiwanese patients.
Chen CH; Hu FC; Huang GT; Lee PH; Tsang YM; Cheng AL; Chen DS; Wang JD; Sheu JC
Eur J Cancer; 2009 Jun; 45(9):1630-9. PubMed ID: 19157858
[TBL] [Abstract][Full Text] [Related]
13. Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma.
Kikuchi LO; Paranaguá-Vezozzo DC; Chagas AL; Mello ES; Alves VA; Farias AQ; Pietrobon R; Carrilho FJ
J Clin Gastroenterol; 2009 Feb; 43(2):191-5. PubMed ID: 19142170
[TBL] [Abstract][Full Text] [Related]
14. Are the Hangzhou criteria adaptable to hepatocellular carcinoma patients for liver transplantation in Western countries?
Audet M; Panaro F; Piardi T; Wolf P
Liver Transpl; 2009 Jul; 15(7):822-3; author reply 824-6. PubMed ID: 19562722
[No Abstract] [Full Text] [Related]
15. Is the search for a single comprehensive staging system for hepatocellular carcinoma an elusive one?
McClune AC; Tong MJ
J Clin Gastroenterol; 2009 Sep; 43(8):697-8. PubMed ID: 19636257
[No Abstract] [Full Text] [Related]
16. Surveillance for hepatocellular carcinoma in patients with liver cirrhosis in India.
Aggarwal R
Trop Gastroenterol; 2008; 29(4):183-6. PubMed ID: 19323085
[No Abstract] [Full Text] [Related]
17. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
18. Complications of cirrhosis.
Ginès P
Semin Liver Dis; 2008 Feb; 28(1):1. PubMed ID: 18293273
[No Abstract] [Full Text] [Related]
19. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics.
Shariff MI; Cox IJ; Gomaa AI; Khan SA; Gedroyc W; Taylor-Robinson SD
Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):353-67. PubMed ID: 19673623
[TBL] [Abstract][Full Text] [Related]
20. [The treatment of hepatocellular carcinoma: an update].
Vero V; Racco S; Biolato M; Pompili M; Gasbarrini G; Miele L; Grieco A
Minerva Med; 2009 Jun; 100(3):173-93. PubMed ID: 19571783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
